Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

ElectroCore Granted FDA Approval For Gammacore Sapphire Neurology Treatment

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K211856

September 13, 2021

1 minute read

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K211856

Credit Suisse Initiates Coverage On Intellia Therapeutics with Outperform Rating, Announces Price Target of $100

Today, 10:40 AM

Credit Suisse initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Outperform rating and announces Price Target of $100.

Today, 10:40 AM

Barclays analyst Jeanine Wai maintains Viper Energy Partners (NASDAQ:VNOM) with a Overweight and lowers the price target from $38 to $37.

Today, 10:40 AM

https://www.engadget.com/google-shipping-and-return-annotations-search-shopping-194556374.html?src=rss

Today, 10:40 AM

Craig-Hallum analyst Eric Des Lauriers maintains Innovative Industrial (NYSE:IIPR) with a Hold and raises the price target from $175 to $240.